Du J - Search Results

1

3D-QSAR study on a series of Bcl-2 protein inhibitors using comparative molecular field analysis.

Hou X, Du J, Fang H, Li M. Hou X, et al. Among authors: du j. Protein Pept Lett. 2011 May;18(5):440-9. doi: 10.2174/092986611794927992. Protein Pept Lett. 2011. PMID: 21171944

2

How to improve docking accuracy of AutoDock4.2: a case study using different electrostatic potentials.

Hou X, Du J, Zhang J, Du L, Fang H, Li M. Hou X, et al. Among authors: du l, du j. J Chem Inf Model. 2013 Jan 28;53(1):188-200. doi: 10.1021/ci300417y. Epub 2013 Jan 2. J Chem Inf Model. 2013. PMID: 23244516

3

Enhancing the Sensitivity of Pharmacophore-Based Virtual Screening by Incorporating Customized ZBG Features: A Case Study Using Histone Deacetylase 8.

Hou X, Du J, Liu R, Zhou Y, Li M, Xu W, Fang H. Hou X, et al. Among authors: du j. J Chem Inf Model. 2015 Apr 27;55(4):861-71. doi: 10.1021/ci500762z. Epub 2015 Mar 16. J Chem Inf Model. 2015. PMID: 25757142

4

Structure-based virtual screening, biological evaluation and biophysical study of novel Mcl-1 inhibitors.

Du J, Liu L, Liu B, Yang J, Hou X, Yu J, Fang H. Du J, et al. Future Med Chem. 2020 Jul;12(14):1293-1304. doi: 10.4155/fmc-2020-0114. Epub 2020 May 13. Future Med Chem. 2020. PMID: 32397829

5

An in silico mechanistic insight into HDAC8 activation facilitates the discovery of new small-molecule activators.

Du J, Li W, Liu B, Zhang Y, Yu J, Hou X, Fang H. Du J, et al. Bioorg Med Chem. 2020 Aug 15;28(16):115607. doi: 10.1016/j.bmc.2020.115607. Epub 2020 Jun 30. Bioorg Med Chem. 2020. PMID: 32690262 Free PMC article.

6

Recent progress in development of cyclin-dependent kinase 7 inhibitors for cancer therapy.

Liang H, Du J, Elhassan RM, Hou X, Fang H. Liang H, et al. Among authors: du j. Expert Opin Investig Drugs. 2021 Jan;30(1):61-76. doi: 10.1080/13543784.2021.1850693. Epub 2021 Jan 11. Expert Opin Investig Drugs. 2021. PMID: 33183110 Review.

7

PTPRO is a therapeutic target and correlated with immune infiltrates in pancreatic cancer.

Hou X, Du J, Fang H. Hou X, et al. Among authors: du j. J Cancer. 2021 Oct 30;12(24):7445-7453. doi: 10.7150/jca.64661. eCollection 2021. J Cancer. 2021. PMID: 35003364 Free PMC article.

8

Discovery of DNA-Targeting HDAC Inhibitors with Potent Antitumor Efficacy In Vivo That Trigger Antitumor Immunity.

Chen C, Li X, Zhao H, Liu M, Du J, Zhang J, Yang X, Hou X, Fang H. Chen C, et al. Among authors: du j. J Med Chem. 2022 Feb 24;65(4):3667-3683. doi: 10.1021/acs.jmedchem.1c02225. Epub 2022 Feb 12. J Med Chem. 2022. PMID: 35152694

9

Structure-Based Design of 2-Aminopurine Derivatives as CDK2 Inhibitors for Triple-Negative Breast Cancer.

Liang H, Zhu Y, Zhao Z, Du J, Yang X, Fang H, Hou X. Liang H, et al. Among authors: du j. Front Pharmacol. 2022 May 3;13:864342. doi: 10.3389/fphar.2022.864342. eCollection 2022. Front Pharmacol. 2022. PMID: 35592410 Free PMC article.

10

Discovery of benzofuran-2-carboxylic acid derivatives as lymphoid tyrosine phosphatase (LYP) inhibitors for cancer immunotherapy.

Liang X, Zhao H, Du J, Li X, Li K, Zhao Z, Bi W, Zhang X, Yu D, Zhang J, Fang H, Hou X. Liang X, et al. Among authors: du j. Eur J Med Chem. 2023 Oct 5;258:115599. doi: 10.1016/j.ejmech.2023.115599. Epub 2023 Jun 28. Eur J Med Chem. 2023. PMID: 37399712

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

16,739 results

Search Page

Filters